Little Green Pharma Ltd. (AU:LGP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Little Green Pharma Ltd reported a substantial 36.8% increase in revenue to $17.5 million for the half-year ended September 2024, driven primarily by sales of medicinal cannabis products. However, the company also faced a 58.7% increase in losses, totaling $3.5 million, due to various expenses despite a positive shift in Adjusted EBITDA and operating cash flow. The company’s financial adjustments included share-based payments and inventory write-downs, reflecting strategic operational changes.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.